Evidence map›Paper›PMID 30951532›Full record

ArticlePloS one2019

Antibody-mediated targeting of cleavage-specific OPN-T cell interactions.

Bettina Wanko, Matteo Tardelli, Alexander Jürets, Angelika Neuhofer, Gerhard Prager, John Morser, Lawrence L Leung, Günther Staffler, Maximilian Zeyda, Thomas M Stulnig

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Bettina WankoClinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University Vienna, Vienna, Austria.ORCID 0000-0001-9169-034X
Matteo TardelliDivision of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2232-7779
Alexander JüretsClinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University Vienna, Vienna, Austria.
Angelika NeuhoferClinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University Vienna, Vienna, Austria.ORCID 0000-0002-8989-6207
Gerhard PragerDepartment of Surgery, Medical University Vienna, Vienna, Austria.
John MorserDivision of Hematology, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0003-3376-8692
Lawrence L LeungDivision of Hematology, Stanford University School of Medicine, Stanford, California, United States of America.
Günther StafflerAFFiRiS AG, Vienna, Austria.ORCID 0000-0003-0025-5081
Maximilian ZeydaClinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University Vienna, Vienna, Austria.
Thomas M StulnigClinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University Vienna, Vienna, Austria.
Medical University of Vienna · ATVA Palo Alto Health Care System · USAFFiRiS (Austria) · AT

Funding

Austrian Science Fund FWF W 1205BLRD VA I01 BX001959
6 · The paper itself

Abstract

T cells are crucial players in obesity-mediated adipose tissue inflammation. We hypothesized that osteopontin (OPN), an inflammatory protein with enhanced activity when proteolytically cleaved, affects the number of viable T cells in adipose tissue and assessed inhibition of the interaction between T cells and thrombin and matrix metalloproteinases-cleaved OPN using antibodies and postimmune sera. Gene expression of T cell markers in adipose tissue from wild-type (wt) and Spp1-/- (OPN deficient) mice was analyzed after 16 weeks of high fat diet (HFD) or low fat diet (LFD) feeding. CD3, CD8 and OPN gene expression in omental adipose tissue from individuals with obesity was measured. OPN-T cell interactions were assessed with a fluorescence-based adhesion assay and blocked with antibodies targeting OPN. Comparison of T cell gene expression in adipose tissue from wt and Spp1-/- mice showed that OPN affected the number of T cells while in humans, levels of OPN correlated with T cell markers in omental adipose tissue. The interaction between T cells and cleaved OPN was blocked by postimmune sera following OPN peptide vaccinations and with monoclonal antibodies. In conclusion, levels of OPN affected the number of T cells in obesity and antibodies against cleaved OPN antagonize OPN-T cell interactions.

Indexed as

Antibody-Dependent Cell CytotoxicityProteolysisAdipose TissueAnimalsAntibodiesCD5 AntigensCD8 AntigensFemaleGene Expression RegulationHumansInflammationMaleMiceMice, KnockoutObesityOsteopontinAntibodiesCD5 AntigensCD8 AntigensOsteopontinSPP1 protein, humanSpp1 protein, mouse

Identifiers

PMID30951532
PMCPMC6450625
OpenAlexW2932143229

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.